- oesophageal/ gastric cancer
- hepatobiliary cancer
- pancreatic cancer
- colorectal cancer
- neuroendocrine cancer
- cancer unknown primary
- anal cancer
Dr Rao has both a private and an NHS practice at The Royal Marsden. She is a Consultant Medical Oncologist specialising in the treatment of upper gastrointestinal (stomach and oesophagus) and hepatobiliary (pancreas, bile duct and liver) malignancies, colorectal (bowel) and neuroendocrine cancers, and cancers of unknown primary.
Dr Rao completed medical training at Charing Cross and Westminster Medical School, general medical training in London and specialist oncology training at The Royal Marsden.
She undertook laboratory-based research at The Institute of Cancer Research examining the prognostic and predictive value of genomic profiling of tumour biopsies in oesophago-gastric cancer. This work was supported by an academic grant and Dr Rao was awarded an MD in 2008.
She serves on the committees for the UK National Cancer Research Institute (NCRI) Colorectal Cancer and Anal-Rectal Clinical Study Groups and is an active member of the International Rare Cancers Initiative (IRCI). She is the Chief Investigator for an international advanced anal cancer trial and principal investigator for other clinical trials. She sits on a number of trial management groups and international data monitoring committees. She serves on the French National Cancer Ethics Committee. Dr Rao is an active contributor to international research through peer review journals and conferences.
She is The Royal Marsden's lead for cancers of unknown primary. Her main interests are the identification of new treatments and translational research for patients with gastrointestinal cancer.